Page last updated: 2024-09-05

zm 241385 and vasoactive intestinal peptide

zm 241385 has been researched along with vasoactive intestinal peptide in 2 studies

Compound Research Comparison

Studies (zm 241385)	Trials (zm 241385)	Recent Studies (post-2010) (zm 241385)	Studies (vasoactive intestinal peptide)	Trials (vasoactive intestinal peptide)	Recent Studies (post-2010) (vasoactive intestinal peptide)
401	3	124	10,873	123	1,221

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, X; Gao, N; Hu, HZ; Liu, S; Wang, GD; Wang, XY; Wood, JD; Xia, Y	1
Cunha-Reis, D; Fontinha, BM; Ribeiro, JA; Sebastião, AM	1

Other Studies

2 other study(ies) available for zm 241385 and vasoactive intestinal peptide

Article	Year
Neurogenic secretion mediated by the purinergic P2Y1 receptor in guinea-pig small intestine. European journal of pharmacology, 2006, Apr-24, Volume: 536, Issue:1-2 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Bumetanide; Chlorides; Dose-Response Relationship, Drug; Electric Stimulation; Electrolytes; Gene Expression; Guinea Pigs; In Vitro Techniques; Intestine, Small; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Vasoactive Intestinal Polypeptide, Type I; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors; Tetrodotoxin; Theophylline; Triazines; Triazoles; Vasoactive Intestinal Peptide	2006
Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus. Neuropharmacology, 2007, Volume: 52, Issue:2 Topics: Adenosine; Adenosine Deaminase; Analysis of Variance; Animals; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Neuroprotective Agents; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Synaptic Transmission; Triazines; Triazoles; Vasoactive Intestinal Peptide; Xanthines	2007

Article

Year

Neurogenic secretion mediated by the purinergic P2Y1 receptor in guinea-pig small intestine.

European journal of pharmacology, 2006, Apr-24, Volume: 536, Issue:1-2

Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Bumetanide; Chlorides; Dose-Response Relationship, Drug; Electric Stimulation; Electrolytes; Gene Expression; Guinea Pigs; In Vitro Techniques; Intestine, Small; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Vasoactive Intestinal Polypeptide, Type I; Signal Transduction; Sodium Potassium Chloride Symporter Inhibitors; Tetrodotoxin; Theophylline; Triazines; Triazoles; Vasoactive Intestinal Peptide

2006

Tonic adenosine A1 and A2A receptor activation is required for the excitatory action of VIP on synaptic transmission in the CA1 area of the hippocampus.

Neuropharmacology, 2007, Volume: 52, Issue:2

Topics: Adenosine; Adenosine Deaminase; Analysis of Variance; Animals; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Membrane Potentials; Neuroprotective Agents; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptor, Adenosine A2A; Synaptic Transmission; Triazines; Triazoles; Vasoactive Intestinal Peptide; Xanthines

2007